SAR Flashcards
overview of the types of SAR strategies
1) analoguing
- similar complexity, systematic stepwise approach, modifying original structure
- pros: explore SAR through specific changes
- cons: broadly similar compounds
- strategies: alkyl substitution, aromatic ring as probe, vinyl group and vinylogues, ring expansion/contraction, ring fusion, extension of structure, homologation, chain branching, bioisosterism, bioisosteric replacement, stereoselectivity in biologically active compounds
2) simplification
- disjunctive approach
- pros: remove unnecessary groups and maintain key interactions
- cons: oversimplication
- strategies: simplification, rigidification
3) adding groups
- conjunctive approach, adding completely new functional groups
- pros: extra functional group added to create/probe for new interactions
- cons: increase MW and potentially hydrophobicity
- strategies: peptidomimetics, ring variation
alkyl substitution
- uses alkyl substituents as probes
- R groups to investigate effect of chain length and bulk at binding site: methyl, ethyl, propyl, butyl, isopropyl, tert-butyl
- R groups interact with hydrophobic pocket to probe depth and length
- increase length +/- bulk of R group = increase binding affinity +/- selectivity
aromatic ring as probe
- change subsitutent on aromatic ring to probe for better interaction at binding site
- alkyl, hydroxyl, halogen
vinyl group and vinylouges
- what is vinyl group? CH2-CH-x
- C=O or -OH at x impart different chemical properties
- enone (x = C=o)susceptible to reaction in vivo w GSH
simplification of structures
- complex leads from natural sources: remove non-essential parts through structural modification
- problems of oversimplification
1) bind differently to target
2) loss of desirable pharmacological activity
3) appearance/increase in SE/toxicity
4) reduce in target selectivity
ring expansion/contraction
- expand or contract 1 unit at a time
ring fusion
- increase interaction/selectivity
- maybe recognise area for better hydrophobic interaction = better binding affinity
- benzylogue used as probe for hydrophobic site
** benzene ring inserted by fusion into structure
extension of structure
- both analoging and adding groups depending on what type of extension
- addition of another functional group to probe for extra binding interaction to target
** hydrophobic for hydrophobic region
** hydrophilic for extra H binding site - convert agonist to antagonist
- convert substrate to inhibitor
homologation
- increase/decrease number of CH2 in aliphatic chain
- influences: lipophilicity (membrane permeability), PK, size/steric property (binding)
- identifying process: stepwise change in n value, lowest IC50 = most optimal length
chain branching
- effects of branching
** branched require lesser water molecules for solvation = more energetically favourable = less lipophilic than linear - types of branching in aliphatic chain: N-butyl, isobutyl, sec-butyl, tert-butyl
- types of branching in amines: pri, sec, tert amines
bioisosterism
- bioesters: groups of molecules w chemical and physical similarities producing broadly similar biological effects
- effects
1) Structural change: size, shape, polarisability, H-bonding
2) receptor interaction: interactive parameters change except for lipid and water solubility
3) PK: moiety for ADME change = change lipophilicity, hydrophilicity, pKa, H bonding
4) metabolism: Affect metabolism if moiety involved in blocking/aiding metabolism
bioesteric replacement
replace atoms/groups that demonstrate similar physicochemical properties
stereoselectivity in biologically active comounds
- explore if there is difference in activity between enantiomers
- 3 point contact model
** 3 point contact required between reacting molecule and binding partner for reaction to occur
** highlight importance of spatial orientation and complementary molecule shapes - ED50: effective dose 50%
- LD50: lethal dose 50%
rigidification
- reduce conformational mobility with ring/bulking groups so that:
1) better binding, less off target effect
2) avoid metabolic enzyme = more stable
peptidomimetics
- peptides not good targets cuz poor F
- peptidomimetics mimic/block biological effect of peptide by interacting with target but without undesirable characteristics
- goal: replace as much of peptide backbone with non peptide fragment while maintaining pharmacophoric groups
- non peptidomimetic: basically replaced all peptides so no longer a peptide anymore